Flosatidil
Alternative Names: SL 851016Latest Information Update: 16 Jan 1996
Price :
$50 *
At a glance
- Originator Sanofi-Synthelabo
- Class Antihypertensives; Antiplatelets; Ischaemic heart disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 25 Oct 1995 New profile
- 25 Oct 1995 Discontinued-II for Angina pectoris in European Union (Unknown route)